Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.

Pilotto A, Franceschi M, Leandro G, Scarcelli C, D'Ambrosio LP, Paris F, Annese V, Seripa D, Andriulli A, Di Mario F.

World J Gastroenterol. 2007 Sep 7;13(33):4467-72.

PMID:
17724802
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole.

Adachi K, Hashimoto T, Hamamoto N, Hirakawa K, Niigaki M, Miyake T, Taniura H, Ono M, Kaji T, Suetsugu H, Yagi J, Komazawa Y, Mihara T, Katsube T, Fujishiro H, Shizuku T, Hattori S, Yamamoto S, Kinoshita Y.

J Gastroenterol Hepatol. 2003 Dec;18(12):1392-8.

PMID:
14675268
[PubMed - indexed for MEDLINE]
5.

Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.

Mee AS, Rowley JL.

Aliment Pharmacol Ther. 1996 Oct;10(5):757-63.

PMID:
8899084
[PubMed - indexed for MEDLINE]
6.

Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

Miner P Jr, Katz PO, Chen Y, Sostek M.

Am J Gastroenterol. 2003 Dec;98(12):2616-20.

PMID:
14687806
[PubMed - indexed for MEDLINE]
7.

Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis.

Yaghoobi M, Padol S, Yuan Y, Hunt RH.

Eur J Gastroenterol Hepatol. 2010 May;22(5):583-90. doi: 10.1097/MEG.0b013e328335d95d.

PMID:
20061959
[PubMed - indexed for MEDLINE]
8.
9.

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Welage LS, Berardi RR.

J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. Review.

PMID:
10665250
[PubMed - indexed for MEDLINE]
10.

Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.

Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.

Digestion. 2003;67(1-2):6-13. Erratum in: Digestion. 2003;67(3):128.

PMID:
12743434
[PubMed - indexed for MEDLINE]
11.

Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.

Inaba T, Mizuno M, Kawai K, Yokota K, Oguma K, Miyoshi M, Take S, Okada H, Tsuji T.

J Gastroenterol Hepatol. 2002 Jul;17(7):748-53.

PMID:
12121503
[PubMed - indexed for MEDLINE]
12.

Lansoprazole: an update of its place in the management of acid-related disorders.

Matheson AJ, Jarvis B.

Drugs. 2001;61(12):1801-33. Review.

PMID:
11693467
[PubMed - indexed for MEDLINE]
14.

Pantoprazole versus lansoprazole in French patients with reflux esophagitis.

Dupas JL, Houcke P, Samoyeau R; French Collaborative Pantaprazole Study Group.

Gastroenterol Clin Biol. 2001 Mar;25(3):245-50.

PMID:
11395670
[PubMed - indexed for MEDLINE]
Free Article
15.

Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate.

Choi HS, Park DI, Hwang SJ, Park JS, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI.

Helicobacter. 2007 Dec;12(6):638-42.

PMID:
18001407
[PubMed - indexed for MEDLINE]
16.

A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.

Jaspersen D, Diehl KL, Schoeppner H, Geyer P, Martens E.

Aliment Pharmacol Ther. 1998 Jan;12(1):49-52.

PMID:
9692700
[PubMed - indexed for MEDLINE]
Free Article
17.

Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group.

Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ.

Aliment Pharmacol Ther. 1999 Jan;13(1):49-57. Erratum in: Aliment Pharmacol Ther 1999 Apr;13(4):567.

PMID:
9892879
[PubMed - indexed for MEDLINE]
Free Article
18.

Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials.

Edwards SJ, Lind T, Lundell L, DAS R.

Aliment Pharmacol Ther. 2009 Sep 15;30(6):547-56. doi: 10.1111/j.1365-2036.2009.04077.x. Epub 2009 Jun 25. Review.

PMID:
19558609
[PubMed - indexed for MEDLINE]
19.

Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.

Pilotto A, Perri F, Leandro G, Franceschi M; Aging and Acid-Related Disease Study Group.

Gerontology. 2006;52(2):99-106.

PMID:
16508317
[PubMed - indexed for MEDLINE]
20.

Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.

Calabrese C, Liguori G, Gabusi V, Gionchetti P, Rizzello F, Straforini G, Brugnera R, Di Febo G.

Aliment Pharmacol Ther. 2008 Jul;28(2):250-5. doi: 10.1111/j.1365-2036.2008.03733.x. Epub 2008 May 12.

PMID:
18485128
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk